Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1) |
| |
| Authors: | Patrick P. Hess,Monica S. Ventura Ferreira,Benjamin Rolles,Martin Kirschner,Florian Holtbernd,Mareike Tometten,Tim H. Brü mmendorf,Fabian Beier |
| |
| Affiliation: | 1. Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, RWTH Aachen University, Aachen Germany ; 2. Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen Germany ; 3. Department of Neurology, Medical Faculty, RWTH Aachen University, Aachen Germany |
| |
| Abstract: | Treatment for Hodgkin lymphoma (HL) in adults comprises substantial risk of chemotherapy‐induced peripheral neurotoxicity. Here, we describe the case of patient with Charcot–Marie–Tooth disease or HSMN1 and advanced Hodgkin lymphoma undergoing treatment with modified BEACOPP achieving complete remission without major aggravation of neurological symptoms. |
| |
| Keywords: | hematology Hodgkin lymphoma neurology neuropathy |
|
|
